إعلان مُمول
Monitor NDMA levels in antacid Ranitidine: Drugs body CDSCO
نشر بتاريخ
Following reports of NDMA impurity, CDSCO has directed state drug controllers to monitor NDMA levels in Ranitidine, a common antacid. An expert panel recommended a larger committee to investigate storage conditions and ICMR to study the drug's safety. Manufacturers are instructed to monitor NDMA levels and take risk-based measures, potentially reducing shelf life.
البحث
الأقسام
- National
- International
- Business
- Technology
- Health
- التعليم
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
إقرأ المزيد
India Champions boycott Pakistan once again
India Champions will not play Pakistan in the World Championship of Legends semi-final. The team...
Trump's judge pick: US President's ex-defence lawyer approved for court of appeal; whistleblower claims denied
Emil Bove, ex-lawyer for Donald Trump, is now a judge. The US Senate confirmed him to the 3rd...
UAE: Will influencers need an advertiser permit to post on social media? What you need to know
New rules are coming to the United Arab Emirates. Now, social media users need a permit for...